NeuroBo Pharmaceuticals completed enrollment of Phase 2a clinical trial for DA-1241 in the treatment of metabolic dysfunction-associated steatohepatitis (MASH).
AI Assistant
METAVIA INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.